Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)

Study:

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)

Rationale:

n/a

Purpose:

This project is designed to evaluate the clinical utility of a novel blood test, the Triage Stroke Panel, as an aid in the diagnosis and assessment of stroke. The Triage Stroke Panel test device, used with the Triage MeterPlus, is a rapid, point-of-care immunoassay. The test measures the concentration of various analytes present in EDTA-anticoagulated whole blood or plasma, specifically B-type natriuretic peptide (BNP), fibrin degradation products containing D-Dimer, matrix metalloproteiase-9 (MMP-9), and S-100B. The test utilizes a proprietary algorithm for the automatic calculation of a single Multimarker Index (MMX) result from the individual biomarker values. The MMX result is being evaluated for use as an aid in the assessment and diagnosis of stroke.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Stroke
Stroke Mimic(Conditions Presenting With Stroke-Like Conditions)
n/a Phase 2/Phase 3

Verified by Biosite April, 2006

Sponsored by: Biosite
Information provided by: Biosite
ClinicalTrials.gov identifier: NCT00206908

Study Type: Interventional

Study Design: Cross-Sectional, Convenience Sample, Retrospective Study

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

Daniel Laskowitz, MD., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site